A Proof of Concept Study of the Effects of LY2828360 in the Treatment of Patients With Osteoarthritic Knee Pain.
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2013
At a glance
- Drugs LY 2828360 (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 20 Apr 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2010-024320-23).
- 09 Mar 2013 Primary endpoint 'Pain-score' has not been met.
- 09 Mar 2013 Primary endpoint 'Pain-intensity-difference' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History